These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5335879)

  • 21. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
    Silver DE; Sahs AL
    Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time].
    Giménez-Roldán S; Mateo D; Gil Núñez A
    Rev Clin Esp; 1980 Dec; 159(6):403-7. PubMed ID: 7221107
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term effects of amantadine in striatal syndromes].
    Rovetta P
    Minerva Med; 1971 Oct; 62(82):3965-7. PubMed ID: 5125054
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromocriptine (ParlodelR) in the treatment of Parkinson's disease.
    Molina-Negro P; Grimes JD; Jones MW; Kofman OS; Bouchard S
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):503-8. PubMed ID: 6761765
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of Parkinson's disease with levodopa. Principles. Practical advice. Considerations].
    Sigwald J
    Nouv Presse Med; 1972 Mar; 1(10):679-82. PubMed ID: 5022921
    [No Abstract]   [Full Text] [Related]  

  • 26. THE EFFECTS OF BIPERIDEN HYDROCHLORIDE (AKINETON) IN POST-ENCEPHALITIC PARKINSONISM.
    MILLER V
    Scott Med J; 1964 Sep; 9():391-3. PubMed ID: 14200166
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxprenolol in Parkinson's disease.
    Jackson R; Crawford CO; Peel JS
    N Z Med J; 1971 Oct; 74(473):246-7. PubMed ID: 4399810
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1969 Oct; 90(5):329-49. PubMed ID: 5406104
    [No Abstract]   [Full Text] [Related]  

  • 29. Delirium caused by intramuscular administration of biperiden.
    Shinohara Y
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E15. PubMed ID: 20463129
    [No Abstract]   [Full Text] [Related]  

  • 30. The Graeme Robertson memorial lecture, 1983. The long-term prognosis of Parkinson's disease.
    Selby G
    Clin Exp Neurol; 1984; 20():1-25. PubMed ID: 6391761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM; Baroni A
    Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticholinergics and dyskinesia.
    Linazasoro G
    Mov Disord; 1994 Nov; 9(6):689. PubMed ID: 7845412
    [No Abstract]   [Full Text] [Related]  

  • 33. Pergolide in the treatment of Parkinson's disease.
    Quinn NP; Lang AE; Thompson C; Brincat S; Marsden CD; Parkes JD
    Adv Neurol; 1984; 40():509-13. PubMed ID: 6695628
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dyskinesia induced by anticholinergic drugs--electrophysiological analysis].
    Mano T
    Rinsho Shinkeigaku; 1974 Mar; 14(3):255-65. PubMed ID: 4153837
    [No Abstract]   [Full Text] [Related]  

  • 35. The etiology of Parkinson's disease.
    Strang RR
    Dis Nerv Syst; 1970 Jun; 31(6):381-90. PubMed ID: 5456765
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 37. [Psychic manifestations during treatment of Parkinson's disease with L-dopa].
    Bonduelle M
    Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897
    [No Abstract]   [Full Text] [Related]  

  • 38. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapeutic effectiveness of modern antiparkinson agents].
    Kurako IuL; Volianskiĭ VE; Fadeev SM
    Vrach Delo; 1981 Feb; (2):7-11. PubMed ID: 7222616
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neurological aspects and modern trends in therapy of Parkinson's disease].
    Pavoncello S; Di Bianco V; Di Castro A; Caviglia A; Cellitti M
    Clin Ter; 1980 Feb; 92(4):433-8. PubMed ID: 7449321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.